BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 3084075)

  • 1. Modification of the cytotoxic activity of mitomycin C by oxygen and ascorbic acid in Chinese hamster ovary cells and a repair-deficient mutant.
    Marshall RS; Rauth AM
    Cancer Res; 1986 Jun; 46(6):2709-13. PubMed ID: 3084075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxicity and DNA lesions produced by mitomycin C and porfiromycin in hypoxic and aerobic EMT6 and Chinese hamster ovary cells.
    Fracasso PM; Sartorelli AC
    Cancer Res; 1986 Aug; 46(8):3939-44. PubMed ID: 3089583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxygen and exposure kinetics as factors influencing the cytotoxicity of porfiromycin, a mitomycin C analogue, in Chinese hamster ovary cells.
    Marshall RS; Rauth AM
    Cancer Res; 1988 Oct; 48(20):5655-9. PubMed ID: 3167822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective removal of DNA cross-links in a repair-deficient mutant of Chinese hamster cells.
    Meyn RE; Jenkins SF; Thompson LH
    Cancer Res; 1982 Aug; 42(8):3106-10. PubMed ID: 6807537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of deficiencies in DNA repair on the toxicity of mitomycin C and porfiromycin to CHO cells under aerobic and hypoxic conditions.
    Hughes CS; Irvin CG; Rockwell S
    Cancer Commun; 1991 Feb; 3(2):29-35. PubMed ID: 1899798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of Chinese hamster ovary cell mutants deficient in excision repair and mitomycin C bioactivation.
    Dulhanty AM; Li M; Whitmore GF
    Cancer Res; 1989 Jan; 49(1):117-22. PubMed ID: 2491748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a set of Chinese hamster ovary variant cell lines demonstrating differing sensitivity to mitomycin C.
    Kuehl BL; Buchwald M; Rauth AM
    Oncol Res; 1993; 5(6-7):213-21. PubMed ID: 8123941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chinese hamster ovary cell lines resistant to mitomycin C under aerobic but not hypoxic conditions are deficient in DT-diaphorase.
    Dulhanty AM; Whitmore GF
    Cancer Res; 1991 Apr; 51(7):1860-5. PubMed ID: 1900739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of NADPH:cytochrome c reductase and DT-diaphorase in the biotransformation of mitomycin C1.
    Keyes SR; Fracasso PM; Heimbrook DC; Rockwell S; Sligar SG; Sartorelli AC
    Cancer Res; 1984 Dec; 44(12 Pt 1):5638-43. PubMed ID: 6437671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The induction of DNA-protein crosslinks in hypoxic cells and their possible contribution to cell lethality.
    Meyn RE; vanAnkeren SC; Jenkins WT
    Radiat Res; 1987 Mar; 109(3):419-29. PubMed ID: 3550869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of mitomycin C with mammalian DNA detected by alkaline elution.
    Dorr RT; Bowden GT; Alberts DS; Liddil JD
    Cancer Res; 1985 Aug; 45(8):3510-6. PubMed ID: 3926301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the superoxide dismutase inhibitor, diethyldithiocarbamate, on the cytotoxicity of mitomycin antibiotics.
    Pritsos CA; Keyes SR; Sartorelli AC
    Cancer Biochem Biophys; 1989 Oct; 10(4):289-98. PubMed ID: 2559790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperthermic enhancement of cell killing by mitomycin C in mitomycin C-resistant Chinese hamster ovary cells.
    Wallner KE; Banda M; Li GC
    Cancer Res; 1987 Mar; 47(5):1308-12. PubMed ID: 3102043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzymatic and pH modulation of mitomycin C-induced DNA damage in mitomycin C-resistant HCT 116 human colon cancer cells.
    Pan SS; Yu F; Hipsher C
    Mol Pharmacol; 1993 Jun; 43(6):870-7. PubMed ID: 8316219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic potential of monoalkylation products between mitomycins and DNA: studies of decarbamoyl mitomycin C in wild-type and repair-deficient cell lines.
    Kim SY; Rockwell S
    Oncol Res; 1995; 7(5):39-47. PubMed ID: 8534933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic potential of monoalkylation products between mitomycins and DNA: studies of decarbamoyl mitomycin C in wild-type and repair-deficient cell lines.
    Rockwell S; Kim SY
    Oncol Res; 1995; 7(1):39-47. PubMed ID: 7549043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferential activation of mitomycin C to cytotoxic metabolites by hypoxic tumor cells.
    Kennedy KA; Rockwell S; Sartorelli AC
    Cancer Res; 1980 Jul; 40(7):2356-60. PubMed ID: 7388797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NRH:quinone oxidoreductase 2 (NQO2) catalyzes metabolic activation of quinones and anti-tumor drugs.
    Celli CM; Tran N; Knox R; Jaiswal AK
    Biochem Pharmacol; 2006 Jul; 72(3):366-76. PubMed ID: 16765324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase) in activation of mitomycin C under acidic conditions.
    Begleiter A; Leith MK
    Mol Pharmacol; 1993 Jul; 44(1):210-5. PubMed ID: 8341273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA repair-deficient Chinese hamster ovary cells exhibiting differential sensitivity to gamma rays under aerobic and hypoxic conditions.
    Rubin JS; Whitmore GF
    Radiat Res; 1985 Mar; 101(3):528-34. PubMed ID: 3983366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.